标题
Rejection versus escape: the tumor MHC dilemma
作者
关键词
MHC class I, Tumor-infiltrating lymphocytes, Immune escape, Tumor rejection, Tumor tissue architecture, PIVAC 15
出版物
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume 66, Issue 2, Pages 259-271
出版商
Springer Nature
发表日期
2016-12-31
DOI
10.1007/s00262-016-1947-x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen
- (2016) R. Andersen et al. CLINICAL CANCER RESEARCH
- The urgent need to recover MHC class I in cancers for effective immunotherapy
- (2016) Federico Garrido et al. CURRENT OPINION IN IMMUNOLOGY
- The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration
- (2016) Francisco Perea et al. INTERNATIONAL JOURNAL OF CANCER
- Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial
- (2016) Roy S Herbst et al. LANCET
- Mutations Associated with Acquired Resistance to PD-1 Blockade in Melanoma
- (2016) Jesse M. Zaretsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- Targetless T cells in cancer immunotherapy
- (2016) Per thor Straten et al. Journal for ImmunoTherapy of Cancer
- Immuno-regulatory antibodies for the treatment of cancer
- (2015) Jamie Honeychurch et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Adenovirus expressing β2-microglobulin recovers HLA class I expression and antitumor immunity by increasing T-cell recognition
- (2014) A B del Campo et al. CANCER GENE THERAPY
- MHC Class I Loss Is a Frequent Mechanism of Immune Escape in Papillary Thyroid Cancer That Is Reversed by Interferon and Selumetinib Treatment In Vitro
- (2014) T. E. Angell et al. CLINICAL CANCER RESEARCH
- CTLA4 Blockade Broadens the Peripheral T-Cell Receptor Repertoire
- (2014) L. Robert et al. CLINICAL CANCER RESEARCH
- Generation of MHC class I diversity in primary tumors and selection of the malignant phenotype
- (2014) Federico Garrido et al. INTERNATIONAL JOURNAL OF CANCER
- Mechanism of tumor rejection with doublets of CTLA-4, PD-1/PD-L1, or IDO blockade involves restored IL-2 production and proliferation of CD8+ T cells directly within the tumor microenvironment
- (2014) Stefani Spranger et al. Journal for ImmunoTherapy of Cancer
- Immune escape of cancer cells with beta2-microglobulin loss over the course of metastatic melanoma
- (2013) Ana B. del Campo et al. INTERNATIONAL JOURNAL OF CANCER
- Microsatellite instability and Beta2-Microglobulin mutations as prognostic markers in colon cancer: results of the FOGT-4 trial
- (2012) A Tikidzhieva et al. BRITISH JOURNAL OF CANCER
- Implication of the β2-microglobulin gene in the generation of tumor escape phenotypes
- (2012) Monica Bernal et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- IFN- in the Treatment of Melanoma
- (2012) A. A. Tarhini et al. JOURNAL OF IMMUNOLOGY
- Antigen Spreading Contributes to MAGE Vaccination-Induced Regression of Melanoma Metastases
- (2011) Véronique Corbière et al. CANCER RESEARCH
- Regression of melanoma metastases after immunotherapy is associated with activation of antigen presentation and interferon-mediated rejection genes
- (2011) Rafael Carretero et al. INTERNATIONAL JOURNAL OF CANCER
- Bacillus Calmette-Guerin immunotherapy of bladder cancer induces selection of human leukocyte antigen class I-deficient tumor cells
- (2010) Rafael Carretero et al. INTERNATIONAL JOURNAL OF CANCER
- Efficient Recovery of HLA Class I Expression in Human Tumor Cells After Beta2-Microglobulin Gene Transfer Using Adenoviral Vector: Implications for Cancer Immunotherapy
- (2009) A. B. del Campo et al. SCANDINAVIAN JOURNAL OF IMMUNOLOGY
- Analysis of HLA class I expression in progressing and regressing metastatic melanoma lesions after immunotherapy
- (2008) Rafael Carretero et al. IMMUNOGENETICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now